VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
KURA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
KURAKura Oncology, Inc.
$11.99$1.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksKURAQuarterly Financials

Kura Oncology, Inc. (KURA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Kura Oncology, Inc. (KURA) quarterly income statement — complete revenue, gross profit & net income history

KURA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue18.27M17.34M20.75M15.29M14.11M53.88M00000000000000
Revenue Growth %29.47%-67.83%------------------
Cost of Goods Sold617K03.21M0000202K234K214K216K000000000
COGS % of Revenue3.38%-15.48%-----------------
Gross Profit17.65M17.34M17.54M15.29M14.11M53.88M0-202K-234K-214K-216K000000000
Gross Margin %96.62%100%84.52%100%100%100%--------------
Gross Profit Growth %25.09%-67.83%-7668.32%6129.06%25278.97%100%-------------
Operating Expenses96.46M103.6M97.53M87.95M78.81M76.34M59.88M56.2M54.22M46.55M42.26M40M36.57M35.16M36.59M35.33M32.78M33.04M33.68M33.65M
OpEx % of Revenue528.13%597.62%470.05%575.31%558.61%141.67%--------------
Selling, General & Admin31.2M39.14M32.84M25.17M22.84M24.07M18.18M16.48M17.95M14.02M12.93M11.82M11.37M12.49M11.62M11.07M11.87M12.08M11.31M12.57M
SG&A % of Revenue170.82%225.77%158.26%164.63%161.86%44.67%--------------
Research & Development65.26M64.41M67.91M62.78M55.97M52.27M41.7M39.73M36.27M32.53M29.33M28.18M25.19M22.67M24.97M24.26M20.91M20.96M22.37M21.07M
R&D % of Revenue357.31%371.53%327.27%410.68%396.75%97%--------------
Other Operating Expenses057K-1000K00000000000000000
Operating Income-78.81M-86.27M-80M-72.67M-64.7M-22.45M-59.88M-56.4M-54.45M-46.76M-42.47M-40M-36.57M-35.16M-36.59M-35.33M-32.78M-33.04M-33.68M-33.65M
Operating Margin %-431.51%-497.62%-385.53%-475.31%-458.61%-41.67%--------------
Operating Income Growth %-21.82%-284.18%-33.59%-28.83%-18.82%51.98%-40.99%-41%-48.91%-33.01%-16.07%-13.22%-11.54%-6.41%-8.66%-5.01%-6.1%-25.47%-39.2%-58.91%
EBITDA-78.46M-85.86M-79.83M-72.44M-71.81M-22.25M-59.68M-56.2M-54.22M-46.55M-42.26M-39.79M-36.36M-34.95M-36.4M-35.15M-32.6M-32.87M-33.52M-33.52M
EBITDA Margin %-429.56%-495.3%-384.74%-473.85%-509.04%-41.3%--------------
EBITDA Growth %-9.25%-285.89%-33.78%-28.9%-32.46%52.2%-41.22%-41.25%-49.11%-33.18%-16.09%-13.2%-11.52%-6.32%-8.6%-4.85%-5.9%-25.35%-38.96%-58.42%
D&A (Non-Cash Add-back)355K403K164K224K-7.12M204K208K202K234K214K216K213K206K206K193K183K177K166K160K124K
EBIT-78.81M-80.58M-74.12M-65.73M-57.59M-16.8M-53.99M-50.43M-49.13M-42.39M-38.2M-36.79M-33.7M-32.88M-35.5M-34.77M-32.45M-32.74M-33.37M-33.36M
Net Interest Income5.49M5.34M5.88M6.54M7.5M5.26M5.48M5.57M4.93M3.98M3.87M2.83M2.5M2.04M1.09M564K329K295K311K-16K
Interest Income5.83M5.69M5.88M6.93M7.88M5.66M5.89M5.97M5.33M4.37M4.28M3.22M2.86M2.27M1.09M564K329K295K311K290K
Interest Expense336K346K0391K382K403K412K406K398K394K404K387K364K229K00000306K
Other Income/Expense5.49M5.34M5.88M6.54M7.5M5.26M5.48M5.57M4.93M3.98M3.87M2.83M2.5M2.04M1.09M564K329K295K311K-16K
Pretax Income-73.33M-80.93M-74.12M-66.12M-57.2M-17.2M-54.4M-50.84M-49.52M-42.79M-38.6M-37.17M-34.07M-33.11M-35.5M-34.77M-32.45M-32.74M-33.37M-33.66M
Pretax Margin %-401.45%-466.82%-357.19%-432.51%-405.46%-31.92%--------------
Income Tax8K71K00226K2.02M00000000000000
Effective Tax Rate %-0.01%-0.09%0%0%-0.4%-11.73%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-73.33M-81M-74.12M-66.12M-57.43M-19.22M-54.4M-50.84M-49.52M-42.79M-38.6M-37.17M-34.07M-33.11M-35.5M-34.77M-32.45M-32.74M-33.37M-33.66M
Net Margin %-401.49%-467.23%-357.19%-432.51%-407.07%-35.66%--------------
Net Income Growth %-27.69%-321.5%-36.23%-30.07%-15.96%55.09%-40.94%-36.75%-45.37%-29.21%-8.73%-6.92%-4.98%-1.13%-6.41%-3.29%-5.73%-25.17%-40.38%-64.31%
Net Income (Continuing)-73.33M-81M-74.12M-66.12M-57.43M-19.22M-54.4M-50.84M-49.52M-42.79M-38.6M-37.17M-34.07M-33.11M-35.5M-34.77M-32.45M-32.74M-33.37M-33.66M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.83-0.92-0.85-0.75-0.66-0.22-0.63-0.59-0.59-0.55-0.50-0.53-0.50-0.49-0.53-0.52-0.49-0.49-0.50-0.51
EPS Growth %-25.76%-318.18%-34.92%-27.12%-11.86%60%-26%-11.32%-18%-12.24%5.66%-1.92%-2.04%0%-6%-1.96%-6.52%-8.89%-19.05%-27.5%
EPS (Basic)-0.83-0.92-0.85-0.75-0.66-0.22-0.63-0.59-0.59-0.55-0.50-0.53-0.50-0.49-0.53-0.52-0.49-0.49-0.50-0.51
Diluted Shares Outstanding88.61M88.05M87.64M87.59M87.42M87.14M86.95M86.64M83.91M77.34M77.24M69.8M68.4M67.78M66.89M66.67M66.61M66.55M66.35M66.28M
Basic Shares Outstanding88.61M88.05M87.65M87.59M87.42M87.14M86.95M86.64M83.91M77.34M77.24M69.8M68.4M67.78M66.89M66.67M66.61M66.55M66.35M66.28M
Dividend Payout Ratio--------------------